During the past decade, Mason District Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 124 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 23 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mason District Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 77 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "NSABP Foundation Inc" with 11 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mason District Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 128 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mason District Hospital" are "Breast Cancer" (28 trials), "Lung Cancer" (18 trials), "Lymphoma" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Leukemia" (8 trials). Many other conditions were trialed in "Mason District Hospital" in a lesser frequency.

Most popular intervention types in "Mason District Hospital" are "Drug" (163 trials), "Other" (78 trials), "Biological" (77 trials), "Radiation" (31 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "placebo" (23 trials), "Bevacizumab" (17 trials), "Paclitaxel" (16 trials) and "carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Mason District Hospital" are 149 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Mason District Hospital". undefined are not yet recruiting, undefined are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 137 completed trials in Mason District Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Mason District Hospital, 12 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".